Search research articles
Contact Us
Filters
Showing results (131-140 of 142) with videos related to
Page
of 15
Sort By:
Behavioural Brain Research
|
October 15, 2016
A novel synthetic cathinone, 2-(methylamino)-1-(naphthalen-2-yl) propan-1-one (BMAPN), produced rewarding effects and altered striatal dopamine-related gene expression in mice
Chrislean Jun Botanas, Seong Shoon Yoon, June Bryan de la Peña, et al.
Neuropharmacology
|
May 23, 2021
R (-)-methoxetamine exerts rapid and sustained antidepressant effects and fewer behavioral side effects relative to S (+)-methoxetamine
Chrislean Jun Botanas, Raly James Perez Custodio, Hee Jin Kim, et al.
Behavioural Brain Research
|
December 31, 2017
A new synthetic drug 5-(2-aminopropyl)indole (5-IT) induces rewarding effects and increases dopamine D1 receptor and dopamine transporter mRNA levels
Chrislean Jun Botanas, Seong Shoon Yoon, June Bryan de la Peña, et al.
Biomolecules & Therapeutics
|
June 25, 2019
Four Novel Synthetic Tryptamine Analogs Induce Head-Twitch Responses and Increase 5-HTR2a in the Prefrontal Cortex in Mice
Arvie Abiero, In Soo Ryu, Chrislean Jun Botanas, et al.
Behavioural Brain Research
|
July 28, 2018
5-Methoxy-α-methyltryptamine (5-MeO-AMT), a tryptamine derivative, induces head-twitch responses in mice through the activation of serotonin receptor 2a in the prefrontal cortex
Arvie Abiero, Chrislean Jun Botanas, Leandro Val Sayson, et al.
Biomolecules & Therapeutics
|
October 31, 2017
Evaluation of the Abuse Potential of Novel Amphetamine Derivatives with Modifications on the Amine (NBNA) and Phenyl (EDA, PMEA, 2-APN) Sites
Raly James Perez Custodio, Chrislean Jun Botanas, Seong Shoon Yoon, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
February 1, 2020
A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension
Woohyeun Kim, Kiyuk Chang, Eun Joo Cho, et al.
Cancers
|
April 3, 2021
Silencing CDCA8 Suppresses Hepatocellular Carcinoma Growth and Stemness via Restoration of ATF3 Tumor Suppressor and Inactivation of AKT/β-Catenin Signaling
Taewon Jeon, Min Ji Ko, Yu-Ri Seo, et al.
Diabetes, Obesity & Metabolism
|
April 23, 2020
Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study)
Gyuri Kim, Soo Lim, Hyuk-Sang Kwon, et al.
Scientific Reports
|
December 11, 2025
Efficacy and safety of pioglitazone versus dapagliflozin as an add-on to metformin and alogliptin combination therapy: the EPIDOTE study
Kyuho Kim, Seung-Hyun Ko, Jae-Seung Yun, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 142) with videos related to
Sort By:
Page
of 15
Behavioural Brain Research
|
October 15, 2016
A novel synthetic cathinone, 2-(methylamino)-1-(naphthalen-2-yl) propan-1-one (BMAPN), produced rewarding effects and altered striatal dopamine-related gene expression in mice
Chrislean Jun Botanas, Seong Shoon Yoon, June Bryan de la Peña, et al.
Neuropharmacology
|
May 23, 2021
R (-)-methoxetamine exerts rapid and sustained antidepressant effects and fewer behavioral side effects relative to S (+)-methoxetamine
Chrislean Jun Botanas, Raly James Perez Custodio, Hee Jin Kim, et al.
Behavioural Brain Research
|
December 31, 2017
A new synthetic drug 5-(2-aminopropyl)indole (5-IT) induces rewarding effects and increases dopamine D1 receptor and dopamine transporter mRNA levels
Chrislean Jun Botanas, Seong Shoon Yoon, June Bryan de la Peña, et al.
Biomolecules & Therapeutics
|
June 25, 2019
Four Novel Synthetic Tryptamine Analogs Induce Head-Twitch Responses and Increase 5-HTR2a in the Prefrontal Cortex in Mice
Arvie Abiero, In Soo Ryu, Chrislean Jun Botanas, et al.
Behavioural Brain Research
|
July 28, 2018
5-Methoxy-α-methyltryptamine (5-MeO-AMT), a tryptamine derivative, induces head-twitch responses in mice through the activation of serotonin receptor 2a in the prefrontal cortex
Arvie Abiero, Chrislean Jun Botanas, Leandro Val Sayson, et al.
Biomolecules & Therapeutics
|
October 31, 2017
Evaluation of the Abuse Potential of Novel Amphetamine Derivatives with Modifications on the Amine (NBNA) and Phenyl (EDA, PMEA, 2-APN) Sites
Raly James Perez Custodio, Chrislean Jun Botanas, Seong Shoon Yoon, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
February 1, 2020
A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension
Woohyeun Kim, Kiyuk Chang, Eun Joo Cho, et al.
Cancers
|
April 3, 2021
Silencing CDCA8 Suppresses Hepatocellular Carcinoma Growth and Stemness via Restoration of ATF3 Tumor Suppressor and Inactivation of AKT/β-Catenin Signaling
Taewon Jeon, Min Ji Ko, Yu-Ri Seo, et al.
Diabetes, Obesity & Metabolism
|
April 23, 2020
Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study)
Gyuri Kim, Soo Lim, Hyuk-Sang Kwon, et al.
Scientific Reports
|
December 11, 2025
Efficacy and safety of pioglitazone versus dapagliflozin as an add-on to metformin and alogliptin combination therapy: the EPIDOTE study
Kyuho Kim, Seung-Hyun Ko, Jae-Seung Yun, et al.
Page
of 15